Kornitzer Capital Management Inc Horizon Therapeutics Public LTD CO Transaction History

Kornitzer Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$107.32 - $113.5 $49,903 - $52,777	-465 Reduced 1.85%	24,700 $2.7 Million
Q4 2022 Feb 02, 2023	SELL	$62.39 - $113.8 $14.2 Million - $25.9 Million	-227,621 Reduced 90.04%	25,165 $2.86 Million
Q3 2022 Nov 03, 2022	SELL	$58.92 - $84.67 $742,038 - $1.07 Million	-12,594 Reduced 4.75%	252,786 $15.6 Million
Q4 2021 Feb 01, 2022	SELL	$98.56 - $119.91 $7,392 - $8,993	-75 Reduced 0.03%	265,380 $28.6 Million
Q3 2021 Nov 03, 2021	BUY	$91.91 - $110.37 $4.24 Million - $5.09 Million	46,145 Added 21.04%	265,455 $29.1 Million

Q2 2021 Jul 30, 2021	SELL	$86.24 - $95.92 $6.98 Million - $7.77 Million	-80,965 Reduced 26.96%	219,310 $20.5 Million
Q1 2021 Apr 30, 2021	SELL	$71.83 - $95.48 $3,950 - $5,251	-55 Reduced 0.02%	300,275 $27.6 Million
Q4 2020 Jan 29, 2021	BUY	$67.0 - $84.39 $18.8 Million - $23.7 Million	280,330 Added 1401.65%	300,330 $22 Million
Q3 2020 Oct 30, 2020	BUY	$55.23 - $79.93 $1.1 Million - $1.6 Million	20,000 New	20,000 $1.55 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.